The European OTC drug market is anticipated to grow at a CAGR of 5.9% during the forecast period. With the increasing healthcare cost, the demand for better accessibility healthcare services at affordable prices increases. Self-medication plays an important role in reducing healthcare costs. The increasing use of OTC drugs in the region is linked with cost benefits, which in turn, is driving the growth of the European OTC drug market.
The European OTC drugs market is segmented based on product type and distribution channels. Based on the product type, the market is sub-segmented into the analgesics & pain relievers; cough, cold & flu products; vitamin & mineral supplements; ophthalmic products; and others. Vitamin & mineral supplements segment is estimated to exhibit a considerable growth rate during the forecast period owing to the increasing awareness among the general population regarding health.
Based on the distribution channel, the market is bifurcated into retail & supermarkets, and online platform. The online distribution channel is estimated to grow at a significant rate during the forecast period owing to the growing e-commerce industry coupled with increasing internet penetration. Further, the report covers the country-level analysis of the UK, Germany, Italy, Spain, France, and the Rest of Europe. Germany is estimated to contribute a significant share in the market. Common OTC drugs available in Germany include Aspirin, Ibuprofen, Dorithricin, Voltaren Gel, and Others
Moreover, the study of the report covers the analysis of various players operating in the market. The European OTC drug market is competitive in nature with the presence of a large number of well-established players in the region. Some of the key players covered in the report include AstraZeneca Plc, Bayer AG, Novartis International AG, Sanofi SA, Perrigo Co. Plc., and others. The players working in the generic medicine industry are making efforts to increase their market share by bringing new OTC drugs into the market.
To Request a Sample of our Report on European OTC Drugs Market: https://www.omrglobal.com/request-sample/european-over-the-counter-otc-drugs-market
European OTC Drugs Market Segment
By Distribution Channel
- Retail & Supermarket
- Online Platform
A full Report of European OTC Drugs Market is Available @ https://www.omrglobal.com/industry-reports/european-over-the-counter-otc-drugs-market
Regional Analysis
- UK
- Germany
- Italy
- France
- Spain
- Rest of Europe
Company Profiles
- AstraZeneca PLC
- Overview
- AstraZeneca Plc in OTC Drugs Landscape
- Recent Developments
- Bayer AG
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline Plc
- Johnson & Johnson Services Inc.
- Merck KGaA
- Novartis international AG
- Perrigo Co. plc
- Reckitt Benckiser Group plc
- Sanofi SA
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404